ArticleBMC cancer2013

Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the invasiveness of endometrial cancer cells through the GnRH-I receptor and mitogen-activated protein kinase (MAPK)-dependent activation of matrix metalloproteinase (MMP)-2.

Hsien-Ming Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.